SS Innovations International (SSII) Non-Current Deffered Revenue (2022 - 2026)
SS Innovations International recorded quarterly Non-Current Deffered Revenue of $7.5 million in Q1 2026, up 5.06% quarter-over-quarter from $7.1 million in Q4 2025, and up 38.78% year-over-year from $5.4 million in Q1 2025.
SS Innovations International's Non-Current Deffered Revenue history runs 5 years deep, the most recent figure standing at $7.5 million for Q1 2026.
- In Q1 2026, Non-Current Deffered Revenue rose 38.78% year-over-year to $7.5 million; the TTM figure through Mar 2026 stood at $7.5 million (up 38.78% YoY), while the FY2025 annual figure was $7.1 million, up 38.0% from the prior year.
- Non-Current Deffered Revenue came in at $7.5 million for Q1 2026 at SS Innovations International, up from $7.1 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $7.5 million in Q1 2026 to a low of $42141.0 in Q4 2022.
- A 5-year average of $3.9 million and a median of $4.3 million in 2024 frame the typical range for Non-Current Deffered Revenue.
- Across the five-year window, Non-Current Deffered Revenue soared 2128.59% in 2023 and soared 38.0% in 2025, its largest moves.
- SS Innovations International's Non-Current Deffered Revenue stood at $42141.0 in 2022, then jumped by 2128.59% to $939150.0 in 2023, then soared by 450.92% to $5.2 million in 2024, then surged by 38.0% to $7.1 million in 2025, then rose by 5.06% to $7.5 million in 2026.
- According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $7.5 million, $7.1 million, and $6.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 512.79 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | SS Innovations International | 770.31 Mn | 746.70 Mn | 5.33 Mn | 7.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.50 Mn |
| Dec 31, 2025 | 7.14 Mn |
| Sep 30, 2025 | 6.28 Mn |
| Jun 30, 2025 | 5.78 Mn |
| Mar 31, 2025 | 5.41 Mn |
| Dec 31, 2024 | 5.17 Mn |
| Sep 30, 2024 | 4.30 Mn |
| Jun 30, 2024 | 3.73 Mn |
| Mar 31, 2024 | 3.13 Mn |
| Dec 31, 2023 | 939,150.00 |
| Sep 30, 2023 | 796,235.00 |
| Jun 30, 2023 | 348,993.00 |
| Dec 31, 2022 | 42,141.00 |